- Iqvia Holdings Inc IQV has collaborated with NRx Pharmaceuticals Inc NRXP to provide pharmacovigilance services and medical information in preparation for potential regulatory actions.
- IQVIA will work closely with NRx to support key activities required for emergency use authorization activation for Zyesami in COVID-19, including the pharmacovigilance and medical information programs.
- Related: NRx Pharma Stock Is Moving Higher On COVID-19 Candidate Data.
- Price Action: NRXP stock is up 6.90% at $11.73 during the premarket session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: BiotechNewsHealth CareContractsSmall CapMoversTrading IdeasGeneralBriefsCOVID-19 Coronaviruswhy it's moving
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
